COVID-19 Switzerland
Information on the current situation, as of 4 October 2022
The key figures will be published each Tuesday at 15:30.
Status report, Switzerland and Liechtenstein
Laboratory-confirmed cases
Source: FOPH – Status: 04.10.2022, 06.08h
| Difference since 27.09.2022 | 25 134 |
|---|---|
| 14-day incidence from 28.09.2022Total per 100 000 inhabitants | 390,52 |
| Total since 06.09.2022 | |
| Number of cases | 68 332 |
| Per 100 000 inhabitants | 784,58 |
Laboratory-confirmed hospitalisations
Source: FOPH – Status: 04.10.2022, 06.08h
| Difference since 27.09.2022 | 290 |
|---|---|
| 14-day incidence from 28.09.2022Total per 100 000 inhabitants | 4,43 |
| Total since 06.09.2022 | |
| Number of hospitalisations | 707 |
| Per 100 000 inhabitants | 8,12 |
Laboratory-confirmed deaths
Source: FOPH – Status: 04.10.2022, 06.08h
| Difference since 27.09.2022 | 13 |
|---|---|
| 14-day incidence from 28.09.2022Total per 100 000 inhabitants | 0,14 |
| Total since 06.09.2022 | |
| Number of deaths | 28 |
| Per 100 000 inhabitants | 0,32 |
Viral load in wastewater
Source: FOPH – Status: 04.10.2022, 08.00h
| Relative viral load | Number of WTTPs | Proportion of WTTPs |
|---|---|---|
| 0-20% | 32 | 29,1% |
| 20-40% | 28 | 25,5% |
| 40-60% | 25 | 22,7% |
| 60-80% | 10 | 9,1% |
| 80-100% | 15 | 13,6% |
| Total | 110 | 100,0% |
Vaccinated people
Source: FOPH – Status: 03.10.2022, 14.40h
| Total population | |
|---|---|
| People with at least one dose | 70,27% |
| Vaccinated in the last six months | 3,85% |
Hospital capacity, Switzerland
Source: FOPH – Status: 04.10.2022, 09.31h
| Intensive care units | |
|---|---|
| Occupancy by COVID-19 patients15-day average from 26.09.2022 | 34,67 |
| Total occupancy | 73,50% |
| Occupancy by COVID-19 patients | 3,90% |
| Total hospital capacity | |
| Total occupancy | 81,50% |
| Occupancy by COVID-19 patients | 4,10% |
Number of beds and occupancy in intensive care units
Virus variants
Source: FOPH – Status: 04.10.2022, 11.17h
Following the lifting of the special situation, the monitoring of variants of the virus will be adapted. There will be fewer numbers of samples sequenced and reporting delays are to be expected.
Estimated share of the different virus variants, 7-day average.
| B.1.351 – Beta7-day average from 13.09.2022 | 0,0% |
|---|---|
| P.1 – Gamma7-day average from 13.09.2022 | 0,0% |
| B.1.617.2, all subvariants AY – Delta7-day average from 13.09.2022 | 0,0% |
| C.37 – Lambda7-day average from 13.09.2022 | 0,0% |
| B.1.1.529 – Omicron7-day average from 13.09.2022 | 100,0% |
Tests and share of positive tests
Source: FOPH – Status: 04.10.2022, 06.08h
| Difference since 27.09.2022 | 71 224 |
|---|---|
| Total since 06.09.2022 | 231 994 |
| PCR tests | 180 199 |
| Rapid antigen tests | 51 795 |
| Per 100 000 inhabitantsCumulative PCR and rapid antigen tests | 2663,73 |
| Share of positive PCR tests | 30,2% |
| Share of positive rapid antigen tests | 38,1% |